Abatacept is effective at reducing pain and fatigue, and improving sleep quality in rheumatoid arthritis patients with an inadequate response to anti-TNF therapy in the attain trial

Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2005

This article is included in 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • ATTAIN [Abatacept Trial in Treatment of Anti-TNF INadequate responders] (15 documents)
Loading references information
This article has no abstract
Epistemonikos ID: 16ba06be9716eca8411632fa92c0844eb00eaf1e
First added on: Oct 21, 2017